Skip to content

Advertisement

Open Access

An acetyl-L-carnitine switch on mitochondrial dysfunction and rescue in the metabolomics study on aluminum oxide nanoparticles

  • Xiaobo Li1,
  • Chengcheng Zhang1,
  • Xin Zhang1,
  • Shizhi Wang1,
  • Qingtao Meng1,
  • Shenshen Wu1,
  • Hongbao Yang2,
  • Yankai Xia3 and
  • Rui Chen1, 4Email author
Contributed equally
Particle and Fibre Toxicology201613:4

https://doi.org/10.1186/s12989-016-0115-y

Received: 14 July 2015

Accepted: 11 January 2016

Published: 16 January 2016

Abstract

Background

Due to the wide application of engineered aluminum oxide nanoparticles and increased aluminum containing particulate matter suspending in air, exposure of human to nano-scale aluminum oxide nanoparticles (Al2O3 NPs) is becoming inevitable.

Methods

In the present study, RNA microarray coupled with metabolomics analysis were used to uncover mechanisms underlying cellular responses to Al2O3 NPs and imply the potential rescue.

Results

We found that Al2O3 NPs significantly triggered down-regulation of mitochondria-related genes located in complex I, IV and V, which were involved in oxidative phosphorylation and neural degeneration pathways, in human bronchial epithelial (HBE) cells. Subsequent cell- and animal- based assays confirmed that Al2O3 NPs caused mitochondria-dependent apoptosis and oxidative stress either in vitro or in vivo, which were consistent with the trends of gene regulation. To rescue the Al2O3 NPs induced mitochondria dysfunction, disruption of small molecular metabolites of HBE were profiled using metabolomics analysis, which facilitates identification of potential antagonizer or supplement against nanoparticle-involved damages. Supplementation of an antioxidant, acetyl-L-carnitine, completely or partially restored the Al2O3 NPs modulated gene expression levels in mitochondrial complex I, IV and V. It further reduced apoptosis and oxidative damages in both Al2O3 NPs treated HBE cells and animal lung tissues.

Conclusion

Thus, our results demonstrate the potential mechanism of respiratory system damages induced by Al2O3 NPs. Meanwhile, based on the metabolomics profiling, application of acetyl-L-carnitine is suggested to ameliorate mitochondria dysfunction associated with Al2O3 NPs.

Keywords

Aluminum oxide nanoparticlesMitochondriaAcetyl-L-carnitineNanotoxicologyMetabolomics

Background

Nano-scale aluminum oxide (Al2O3) particles are widely used in insulator layers, powder coating, and fluorescent lamp material. Meanwhile, aluminum (Al) is a common metal component in ultrafine airborne particles (PM2.5) in the ambient environment1,2 and is relatively stable in the form of aluminum oxide. These ultrafine aluminum particles have different physical, chemical, and biological characteristics, and are likely to be more toxic than the same conventional sized materials [1]. Thus, increased and inevitable occupational and environmental exposures to ultrafine Al2O3 particles are considered as a health risk, while, prevention or intervention measures have not been investigated. Generally, ultrafine particles can be inhaled more deeply than large particles, leaving sediment on the surface of the trachea, bronchus, and alveoli. Lung tissue is considered the primary target organ for inhaled ultrafine particles. Accordingly, aluminum oxide nanoparticles (Al2O3 NPs) were employed as an ultrafine particle model to explore the impacts of aluminum ultrafine particles on the respiratory system.

Apoptosis is an endpoint to assess toxicity of metal oxide nanomaterial, providing a benchmark against which to evaluate the potential toxicity of engineered nanoparticles [24]. There are two major apoptotic pathways initiated by either mitochondria or cell surface receptors [5]. Mitochondria-mediated apoptosis is also called the ‘intrinsic’ pathway and occurs in response to a wide range of death stimuli, and is characterized by cascade reactions including mitochondrial outer membrane permeabilization (MOMP), release of cytochrome c into the cytoplasm to activate caspase-9 and subsequent caspase-3 [5, 6]. The intrinsic pathway is involved in immune disorders [7], neurodegeneration [8] and cancer [9, 10]. Studies investigating ambient particulate matter or nanoparticles suggest apoptosis or mitochondrial dysfunction are sufficient end-points to monitor toxicity [1113], but conventional toxicity assays may not suffice to fully understand the cellular responses of ultrafine particle exposure. Thus, a more comprehensive approach to determining how cells respond to ultrafine particles is required.

“Omics” analysis, including transcriptomics, proteomics, and metabolomics, coupled with appropriate computational approaches to determine statistically significant gene, protein, metabolite or pathway regulation can be used as a tool to identify the potential hazards and mechanisms of nanoparticle toxicology [1416]. These newly developed high-throughput approaches have been used to study the impact of nanomaterials, including metal and metal oxide nanoparticles [1719]. In such studies, the “omics” technologies are used to predict interaction between nanoparticles and biological systems, facilitate assessment of systemic toxicity due to nanomaterials, reveal potential strategies for risk mitigation.

Metabolomics analysis is one of the most applied “omics” analysis that facilitates understanding of the modulation of small molecules following exposure. Acetyl-L-carnitine (ALCAR), an antioxidant dietary supplement, could be detected through GC/TOF/MS analysis and plays a vital role in oxidation of fatty acid metabolic pathways. It is a constituent of the inner mitochondrial membrane and has many fundamental functions, including acetyl CoA uptake [20], improving mitochondrial bioenergetics [21] and prevention of mitochondrial enzyme oxidation [22]. The acetyl group of ALCAR is used to produce the antioxidant glutathione (GSH), reducing oxidative stress, and protecting cells against lipid peroxidation [23, 24]. ALCAR also contributes to the bioenergetics processes, therefore, it plays a vital role in mitochondrial-related disorders [25, 26].

Here, we used human bronchial epithelia (HBE) as a model system due to their importance in defense against inhaled pathogens and particulates [27]. We investigated changes in gene expression profiles and small molecular metabolites in HBE cells induced by Al2O3 NPs. Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) were used to evaluate pathways. We showed that Al2O3 NPs are capable of triggering specific changes in HBE cell gene expression, specifically in mitochondria associated genes. We assessed mitochondria-mediated apoptosis in the presence or absence of acetyl-L-carnitine as a supplement to oppose mitochondrial dysfunction caused by Al2O3 NPs. The pathological alterations and ALCAR rescue were observed in mouse lung tissues treated with Al2O3 NPs. Our results suggests Al2O3 NPs cause toxicity and mitochondrial dysfunction that may be remedied by acetyl-L-carnitine treatment.

Results

Overview of mRNA microarray profiles

To determine how gene transcription was altered due to Al2O3 NP exposure, HBE cell mRNA profiling was evaluated by RNA microarray. As shown in Fig. 1a, Al2O3 nanoparticles exerted specific transcriptional effects leading to significantly increased expression of 54 genes and decreased expression of 304 genes, with a cutoff as 2 or more fold change and P < 0.05. GO enrichment classifies transcriptional changes observed between control and treatment groups. Notably, the GO analysis revealed that genes encoding proteins necessary for mitochondrial function were differentially expressed. Significantly, of the genes differentially regulated, 23/ 154 genes involved in cell components (CC) (Fig. 1b); 11/85 genes involved in molecular function (MF) (Fig. 1c), and 14/183 in biological process (Fig. 1d). These mitochondria involved enrichment were labeled with red color in Fig. 1. Therefore, a total of 27 mitochondrial related genes were identified, the fold change, P value and functions of their encoded proteins are shown in Table 1.
Figure 1
Fig. 1

An overview of RNA microarray profiles. a Volcano diagram depicting the differentially expressed genes identified by a linear model of limma Software Package. Each red point corresponds to one differentially expressed gene. Heat map of samples based on the RNA microarray gene expression profiles. The down-regulation and up-regulation of genes were expressed by green color and red color correspondingly. b sub-ontology cellular component (CC) of gene ontology enrichment c) the sub-ontology molecular function (MF) shows mitochondria are the mostly involved enrichment categories. d sub-ontology of biological process (BP). The mitochondria-invovled GO enrichments were labeled with red

Table 1

Modulated genes involved in mitochondrial functions

Gene symbol

Main functions

Adjusted P value

Fold change

NDUFA4

NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4

6.73E-06

2.365756

NDUFA2

NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 isoform 1

3.02E-06

0.374527

NDUFS4

NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial precursor

4.13E-06

0.396259

UQCR11

ubiquinol-cytochrome c reductase, complex III subunit XI [Source:HGNC Symbol;Acc:30862]

4.01E-06

2.23789

COX7B

cytochrome c oxidase subunit 7B, mitochondrial precursor

2.16E-07

0.284784

NDUFC2

NADH dehydrogenase [ubiquinone] 1 subunit C2 isoform 1

4.23E-07

0.262135

NDUFA1

NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1

3.91E-08

0.217706

ATP5H

ATP synthase subunit d, mitochondrial isoform b

3.12E-06

0.400955

TXNDC17

thioredoxin domain-containing protein 17

9.85E-03

2.426058

ATP5S

ATP synthase subunit s, mitochondrial isoform b precursor

6.20E-03

0.273283

ATP6V0B

V-type proton ATPase 21 kDa proteolipid subunit isoform 2

1.34E-03

0.450262

CS

citrate synthase, mitochondrial precursor

7.27E-05

0.464647

DLST

dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial isoform 1 precursor

4.25E-04

0.486408

JUN

transcription factor AP-1

8.43E-04

0.447503

NDUFB11

NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial isoform 1

2.57E-02

2.051124

SOD2

superoxide dismutase [Mn], mitochondrial isoform A precursor

6.44E-06

0.476653

TP73

tumor protein p73 isoform d

2.15E-02

0.403954

ATPIF1

ATPase inhibitor, mitochondrial isoform 1 precursor

8.80E-04

2.074952

COX17

cytochrome c oxidase copper chaperone

6.79E-08

0.255958

MRPL11

39S ribosomal protein L11, mitochondrial isoform a

4.50E-06

0.159154

PMPCB

mitochondrial-processing peptidase subunit beta precursor

4.50E-06

0.352621

CYP11A1

cholesterol side-chain cleavage enzyme, mitochondrial isoform a precursor

4.45E-05

2.955856

MRPL52

mitochondrial ribosomal protein L52

2.41E-05

0.452092

HAAO

3-hydroxyanthranilate 3,4-dioxygenase

1.34E-03

0.376486

TOMM20

mitochondrial import receptor subunit TOM20 homolog

6.86E-07

0.321764

MRPL39

39S ribosomal protein L39, mitochondrial isoform b

1.16E-06

0.38445

HSPE1

10 kDa heat shock protein, mitochondrial

2.73E-08

0.239258

Subsequently, these 27 genes were subjected to KEGG pathway enrichment analysis. These selected genes were annotated with the KEGG pathway database and hypergeometric tests were used to estimate the significance of enrichment. Among these pathways, mitochondrial function and neural system disease were significantly enriched (Fig. 2a). Figure 2b is schematic oxidative phosphorylation pathway by KEGG. Our microarray data suggested that NADH ubiquinone oxidoreductase-encoding genes (NDUFA2 and NDUFS4), NADH dehydrogenase-encoding genes located in mitochondrial complex 1 (NDUFC2, NDUFA1, and NDUFA4), NADH ubiquinol-cytochrome c reductase gene UQCR11 (complex III), cytochrome c oxidase genes (COX7B and COX17 (complex IV)), and the mitochondrial ATP synthase gene ATP5H (complex V, F0 unit) were among the most affected genes. The down-regulated genes were noted with blue color and the up-regulated gene was noted with red color in Fig. 2b.
Figure 2
Fig. 2

KEGG pathway enrichment analysis of mitochondria related genes. a A total of 27 mitochondria related genes were analyzed through DAVID functional annotation cluster tool. These genes mainly are involved in five KEGG pathways. Oxidative phosphorylation is the most significant enrichment. b A schematic figure of the oxidative phosphorylation pathway by KEGG. mRNA microarray assay predicted up-regulated genes are stainded red, and down-regulated genes are stained blue in this schematic figure

Levels of mRNA expression were confirmed by qRT-PCR

To validate our RNA microarray data, we performed qRT-PCR to validate 11 differentially expressed mitochondrial genes that involved in at least two enrichments in GO categories. In HBE cells and lung tissue obtained from mice treated with Al2O3 NPs, UQCR11 was upregulated and NDUFA4, NDUFA2, NDUFS4, COX7B, NDUFC2, NDUFA1, ATP5H, COX17, DLST, and CS were downregulated in a dose-dependent manner (Fig. 3a and b). With the exception of NDUFA4, which was down-regulated by qRT-PCR analysis, the trend in mRNA regulation of the other 10 genes was consistent between microarray and qRT-PCR (Fig. 3c).
Figure 3
Fig. 3

qRT-PCR validation of the expression levels of modulated mitochondria-related mRNA. a Mitochondria-related gene expression level in HBE cells treated with 50, 100, 250 or 500 μg/ml Al2O3 NPs. Gene expression is regulated in a dose-dependent manner b: Gene expression level of lung tissues in mice exposed to Al2O3 NPs through inhalation. Gene expression is regulated in a dose-dependent manner. c Except NDUFA4, fold change of modulated genes in cells treated with 100 μg/ml Al2O3 NPs are consistent with array data

Apoptosis is induced in HBE cells and lung tissue following Al2O3 NPs exposure

Cytotoxicity of Al2O3 NPs was evaluated by CCK-8 assay. HBE cells were exposed to Al2O3 NPs at different doses (12.5-1000 μg/ml) every 24 h up to 7 days. 100 μg/ml or higher doses showed significant toxicity to HBE cells 24 h after treatment (Fig. 4a). To further verify that Al2O3 NP exposure caused apoptosis, cells was assessed by flow cytometric analysis of annexin V-FITC and PI double staining. After 12 h treatment, significant enhancement of apoptosis (2.24 ± 0.17 %) was observed only in 500 μg/mL Al2O3 NPs HBE cells (Additional file 1: Figure S1A). Further, apoptosis occurred 8.98 ± 0.39 % and 16.77 ± 0.57 % in HBE cells treated with 100 or 500 μg/mL Al2O3 NPs for 24 h, respectively, but significant increase of cellular necrosis was not observed at either treatment concentrations (Fig. 4b). To determine pathways induced by Al2O3 NP exposure, caspase-3, 8, and -9 activities were evaluated. Increased activities of caspase-3 and -9 were shown in Al2O3 NPs treated groups, suggesting HBE cell apoptosis is initiated by the intrinsic pathway (Fig. 4c). Similar results were obtained from lung tissues harvested from mice treated with Al2O3 NPs (Fig. 4c).
Figure 4
Fig. 4

Cell viability and apoptosis of HBE cells after exposure to Al2O3 NPs. a Cell viability of HBE cells were analyzed through CCK-8 assays after exposure to Al2O3 NPs. b Apoptosis induction was significantly enhanced by Al2O3 NP exposure, and the proportion of necrosis was not significantly modulated c) Assessments of caspase-3, -8, and -9 activities in HBE cells and lung tissues harvested from mice treated with Al2O3 NPs. The increase of caspase-9 and -3 suggested that Al2O3 NPs induced apoptosis in HBE are mitochondria involved. * P < 0.05, compared with untreated control

H&E and TUNEL staining was performed to detect pathology and programmed cell death in situ. Inflammation and red blood cell located in pulmonary mesenchyme were observed in both low and high dose exposed mice lung tissue. The typical pathological alterations were showed in Fig. 5. Figure 5a showed a normal structure of lung tissue. As shown in Fig. 5b, pneumorrhagia characterized by interstitial red blood cells distribution was seen in lung tissue obtained from mice treated with low dose Al2O3 NPs. Massive lymphocytes infiltration, especially the subpleural area, were observed in high dose Al2O3 NPs treated mice lung tissue (Fig. 5c). The pathological lesions scores were showed in Fig. 5g. Compared with control group, the pathological lesion score increased significantly in both nanoparticle treated lung tissues (P < 0.05), However, high dose exposure did not enhance the pathological lesions in lung tissue significantly when compared with low Al2O3 NPs treatment. For both treatment groups, pathological scores suggested mild to moderate alveolitis in lung tissues of mice, further, following ALCAR rescue, the alveolitis were attenuated to mild degree. ALCAR ameliorated the damages against Al2O3 NPs significantly (P < 0.05), compared with corresponding Al2O3 NPs treated groups.
Figure 5
Fig. 5

HE and TUNEL staining of lung tissues harvested from mice exposed to Al2O3 NPs. a HE staining of control mice lung tissue b) arrows showed pneumorrhagia in lung tissue from 2 mg/m3 Al2O3 NP exposure c) arrows demonstrated lymphocytes infiltration of lung tissue due to exposure to 10 mg/m3 Al2O3 NPs d) few apoptosis cells were observed in control mice lung tissue by TUNEL staining e) massive apoptosis in bronchial epithelia were induced by 10 mg/m3 Al2O3 NP exposure as shown by arrows f) ALCAR supplement reduced apoptosis of bronchial epithelia in 10 mg/m3 Al2O3 NP exposed mice lung tissue. The arrows show apoptotic epithelial cells. g The pathological lesion score of mice lung tissues h) Proportion of TUNEL-positive bronchial epithelia within each group. * P < 0.05, compared with untreated control. # P < 0.05, compared with corresponding control

TUNEL-positive cells were not observed in the bronchial epithelia in untreated mice lung (Fig. 5d). Treatment with 10 mg/m3 Al2O3 NPs resulted in degeneration of lung cells and the massive bronchial epithelial cells had significant apoptosis (Fig. 5e) Ameliorated apoptosis was observed in bronchial epithelia of mice exposed to high dose Al2O3 NPs following ALCAR rescue (Fig. 5f). The proportion of TUNEL-positive bronchial epithelia were showed in Fig. 5h. For both low and high dose Al2O3 NPs treatment, ALCAR could partially rescue apoptosis of bronchial epithelia to control level.

Dysfunction of mitochondria induced by Al2O3 NPs

The mitochondria-mediated apoptosis pathway is characterized by destruction of mitochondrial membrane potential and subsequent release of cytochrome c into the cytoplasm [6], accompanied by decreased ATP synthesis. The fluorescent probe JC-1 staining showed red fluorescence in normal cells, indicating intact mitochondrial membrane potential, while cells treated with 100 and 500 μg/ml Al2O3 NPs were stained green after 12 or 24 h treatment, indicating clear damage to the mitochondrial membrane potential as shown in Additional file 1: Figure S1B and Fig. 6a. Additionally, cytoplasmic cytochrome c significantly increased in cells treated with Al2O3 NPs (Fig. 6b), however, this was lower than the positive control (CCCP).
Figure 6
Fig. 6

Mitochondrial dysfunction is observed in both HBE cells and in lung tissues treated with Al2O3 NPs. a JC-1 staining showed alteration of mitochondrial membrane potential. The left panel shows cells from control group indicating that only red fluorescence was observed. After treatment with 100 or 500 μg/ml Al2O3 NPs, increased green fluorescence and decreased red fluorescence were observed, which suggested collapse of mitochondrial membrane potential. CCCP was employed as positive control and demonstrated strong damages to mitochondrial membrane potential b) Cytochrome c is released from mitochondria, therefore, cytosol cytochrome c concentration was enhanced in HBE cells. Meanwhile ATP synthesis decreased in both HBE cells and lung tissues exposed to Al2O3 NPs. * P < 0.05, compared with untreated control, # P < 0.05, compared with positive control (CCCP)

ATP levels were detected by luminometer after 24 h exposure. In both HBE cells and lung tissues from mice treated with Al2O3 NP, ATP decreased compared to the control (Fig. 6b). Collectively, our results suggest Al2O3 NPs exposure is cytotoxic.

Al2O3 NPs induce oxidative stress in both HBE cells and mice lung tissues

To assess the importance of oxidative stress in Al2O3 NP cytotoxicity, ROS, H2O2, O2 .- and MDA levels were evaluated in HBE cells 12 or 24 h after treatment. Correspondingly, ROS and MDA levels were evaluated in mice lung tissues. ROS generation is a main cause of mitochondria-dependent apoptosis. We used DCFH-DA as a reporter of ROS generation, and as shown in Fig. 7a, level of ROS increased in cells treated with Al2O3 NPs for 24 h, indicated by higher intensity of fluorescence. As shown in Additional file 1: Figure S1C and Fig. 7b, Al2O3 NP treatment significantly increased ROS and O2 .- levels, but not H2O2 levels, in HBE cells. Comparable results were observed in lungs obtained from mice treated with Al2O3 NPs. Similarly, MDA, the end product of lipid peroxidation, also increased as shown in Fig. 7b and Additional file 1: Figure S1C. For all of these oxidative stress-involved assays, the positive control (CCCP) demonstrated stronger stimulus to HBE cells than Al2O3 NPs.
Figure 7
Fig. 7

Oxidative stress and lipid peroxidation induced by Al2O3 NP exposure. a ROS is induced by Al2O3 NP exposure in HBE cells with increased green fluorescence. CCCP was employed as positive control. b ROS, O2 .- and lipid peroxidation production MDA are increased in HBE cells and mouse lungs following Al2O3 NP exposure. The H2O2 level is not affected by Al2O3 NPs exposure in HBE cells. * P < 0.05, compared with untreated control, # P < 0.05, compared with positive control (CCCP)

Metabolic analysis showed up- and down- regulated metabolites of HBE cells

According to PCA analysis, significant differences were observed between control HBE cells and HBE cells treated with either 100 μg/ml or 500 μg/ml Al2O3 NPs (Additional file 1: Figure S2). We used MetaboAnalyst to identify key metabolism alterations between untreated and treated HBE cells. After Bonferroni correction (p cut-off < 0.00001), we found 9 down-regulated and 11 up-regulated small molecules in treated samples in a dose-dependent manner (Table 2). Among differentially regulated metabolites, acetyl-L-carnitine (ALCAR) (p = 3.64E−09), 4-Methoxyphenylacetic acid (p = 7.61E−07) and thymine (p = 2.99E−07) were the lowest in P value. Because ALCAR is important for mitochondrial function, it could be a candidate supplement to rescue the adverse effects of Al2O3 NPs on HBE cells.
Table 2

Metabolomics analysis of Al2O3 NPs exposed HBE cell lysates

Peak

Metabolic pathway

HMDB

Regulation

3-Phenylbutyric Acid

Taurine and Hypotaurine Metabolism

HMDB01955

down

Melatonin

Tryptophan Metabolism

HMDB01389

down

cis-Aconitic acid

Citric Acid Cycle

HMDB00072

down

3-Methylhistidine

Histidine Metabolism

HMDB00479

down

Acetyl-L-carnitine

Beta Oxidation of Very Long Chain Fatty Acids

HMDB00201

down

4-Methoxyphenylacetic acid

Tyrosine Metabolism

HMDB02072

down

N-Acetyl-L-methionine

Betaine Metabolism

HMDB11745

down

N-Formyl-L-methionine

Betaine Metabolism

HMDB01015

down

Pyridoxal 5′-phosphate

Vitamin B6 Metabolism

HMDB01491

down

L-Serine

Homocysteine Degradation

HMDB00187

up

Adenine

Phytanic Acid Peroxisomal Oxidation

HMDB00034

up

Succinic acid

Aspartate Metabolism

HMDB00254

up

D-Glutamic acid

Glutamate Metabolism

HMDB03339

up

Thymine

Pyrimidine Metabolism

HMDB00262

up

Ethylmalonic acid

Mefanamic Acid Pathway

HMDB00622

up

Ureidopropionic acid

Beta-Alanine Metabolism

HMDB00026

up

(-)Matairesinol

Phenylacetate Metabolism

HMDB35698

up

Taurocholic Acid

Bile Acid Biosynthesis

HMDB00036

up

Docosahexaenoic acid

Mefanamic Acid Pathway

HMDB02183

up

Pyridoxine

Vitamin B6 Metabolism

HMDB00239

up

Protective effects of ALCAR to HBE cells against Al2O3 NPs induced mitochondria dysfunction and oxidative stress

To test whether ALCAR could reduce cell toxicity due to Al2O3 NPs, toxicity was evaluated in cells treated with 0.1 or 0.3 mg/ml ALCAR at treatment with 500 μg/ml Al2O3 NPs. As shown in Fig. 8a, 0.3 mg/ml ALCAR treatment significantly reduced the cell viability loss in both 100 and 500 μg/ml Al2O3 NP treated cells, and was used as a therapeutic dose for the remaining experiments. Compared to untreated cells and lungs, co-treatment with ALCAR attenuated caspase-3 and -9 activities as shown in Fig. 8b. Caspase-8 activity was not affected by ALCAR treatment (Fig. 8b). To confirm ALCAR treatment reduced apoptosis, treated cells were evaluated by annexin-V and PI staining. Similarly, 0.3 mg/ml ALCAR treatment reduced annexin-V staining significantly (Fig. 8c). ALCAR treatment also reduced production of intracellular ROS, O2 .- and MDA in HBE cells and lungs harvested from mice treated with Al2O3 NPs as shown in Fig. 9a and b. ALCAR could only partially rescue HBE cells against CCCP induced oxidative stress (Fig. 9a). ALCAR also demonstrated protective effects to mice bronchia epithelia from apoptosis (Fig. 5f).
Figure 8
Fig. 8

The ameliorative effects of ALCAR supplementation against cell viability lost and apoptosis. a 0.3 mg/ml ALCAR co-treatment effectively increased cell viability. b 0.3 mg/ml ALCAR co-treatment with Al2O3 NPs ameliorated activities of caspase-3 and -9 completely or partially to control level in HBE cells by c) 0.3 mg/ml ALCAR co-treatment partially protected HBE cells from apoptosis induced by Al2O3 NPs. * P < 0.05, compared with untreated control, # P < 0.05, compared with corresponding control within each treatment group

Figure 9
Fig. 9

Oxidative stress and lipid peroxidation are reduced after ALCAR rescue. a Oxidative stress and lipid peroxidation are reduced by ALCAR supplementation in HBE cells and b) lung tissues from mice treated with Al2O3 NPs. * P < 0.05, compared with untreated control, # P < 0.05, compared with corresponding control within each treatment group

Gene expression levels in HBE cells and mouse lung tissues after ALCAR treatment were evaluated by qRT-PCR. Altered expression of genes located in mitochondria complex IV and V, COX7B, COX17 and ATP5H, was comparable to control cells following ALCAR treatment. Expression of genes in complex I, including NDUFA1, NDUFA2, NDUFA4, NDUFC2 and NDUFS4 were partially normalized following ALCAR treatment. UQCR11, DLST, and CS expression was unresponsive to ALCAR treatment (Fig. 10).
Figure 10
Fig. 10

Gene expression levels after ALCAR rescue. a Expression levels of genes located in complex I, IV and V are partially or completely normalized after ALCAR rescue in HBE cells and in b) lung tissues from mice exposed to Al2O3 NPs

Discussion

Using high-throughput mRNA sequencing and computational approaches, we showed that Al2O3 NPs cause changes in gene expression in HBE cells. Among the differentially expressed genes, mitochondrial genes were among the most significantly affected category. Further, cell and animal based functional assays confirmed that Al2O3 NPs caused mitochondrial dysfunction and oxidative stress in HBE cells and mouse lung tissue. Metabolomics analysis showed downregulation of ALCAR in HBE lysate in a dose-dependent manner following Al2O3 NP treatments. Co-treatment of cells with ALCAR and Al2O3 NPs prevented mitochondrial dysfunction both in vivo and in vitro.

Inhalation is one of the major exposure routes for nano-scale materials, including engineered nanoparticles and ambient particulate matter (PM), which have effects on the respiratory system [28]. Various nanoparticles are reported to produce pulmonary lesions. For example, respiratory administration of single-walled carbon nanotubes (SWCNTs) increased collagen and alveolar wall thickness [29]. Well dispersed nickel-oxide nanoparticles increase inflammation and cytotoxicity in C57BL/6 J mice lung tissues [30]. Transcriptomic and proteomic approaches implicate that inflammation and oxidative stress are involved in pulmonary toxicity caused by silica nanoparticles [31]. Chronic exposure to ambient PM can cause lung remodeling, with particle deposition on terminal bronchioles and first-generation respiratory bronchioles [32]. Though aluminum is considered as a neural toxin, lung tissue could be the primary organ affected by inhaled nano-scale Al2O3 particles from either engineered or ambient sources. According to the Chinese Health standard for dusts of aluminum, aluminum oxide, and aluminum alloys in the air of workplace (GB11726-89), the maximum allowable concentration for Al2O3 powder in air is 6 mg/m3. Among these suspended particles, the health effects of nano-scaled Al2O3 particles should be intensively considered due to its longer suspension and lower deposition in respiratory system than other large particles. In the present study, the exposure doses of Al2O3 NPs to mice were set to 2 or 10 mg/m3 to evaluate the potential pulmonary damages.

Mitochondrial function was used as an indicator to evaluate the biological effects of various nanomaterials [33]. Copper oxide nanoparticles induce apoptosis in human hepato-carcinoma (HEPG2) cells through the intrinsic apoptosis pathway, which is accompanied by increased reactive oxygen species generation and oxidative stress and the collapse of mitochondria membrane potential [34]. Nymark et al [33] combined transcriptome and microRNA analysis to identify mitochondrial dysfunctions induced by multi-walled carbon nanotubes and 26 genes with known mitochondrial function were identified. Additionally, GO analysis showed that the most significantly enriched biological process among the 26 differentially expressed genes was gluconeogenesis. Our studies suggest mRNA profiling analysis is a reasonable strategy to study the Al2O3 NP toxicity on HBE cells. A total of 27 genes associated with the mitochondria correlated to Al2O3 NP treatment. In contrast to Nymark’s results, our array data suggested that oxidative phosphorylation was the most significantly affected biological process in treated cells. Gene expression levels were confirmed by qRT-PCR in HBE cells and mouse lung tissues exposed to Al2O3 NPs, further implicating altered mitochondrial function.

Mitochondria-mediated apoptosis is initiated by mitochondrial outer membrane permeabilization and release of cytochrome c into the cytoplasm [6]. Cytochrome c binds to apoptosis protease activating factor-1 (Apaf-1), which leads to activation of caspase-9 and -3, and is essential for DNA damage and apoptosis [35]. To determine whether differential expression of mitochondrial genes may lead to apoptosis, we monitored cell viability and mitochondrial function in cells and tissues exposed to Al2O3 NPs. Decreased mitochondrial membrane potential, increased caspase-9 and -3, and increased apoptosis were observed in cells and lung tissues exposed to Al2O3 NPs, suggesting Al2O3 NPs causes cytotoxic effects in the pulmonary tract.

Mitochondria are the primary source of cellular ROS, produced through oxidative phosphorylation, especially at levels of complexes I and III of the respiratory chain [36]. Excessive ROS production can lead to mitochondrial oxidative damage, which can lead to cell apoptosis. O2 .- is an indicator of mitochondrial ROS production, and is generated by the addition of one electron to O2. Most intracellular ROS are derived from superoxide O2 .- and elicit various pathological events, including DNA damage and apoptosis [3739]. Due to the small size and large surface area of nanoparticles, ROS are usually produced when cells are exposed to nanoparticles. As a result, oxidative stress and lipid peroxidation have been hypothesized to play an important role in nanoparticle toxicity [34, 40]. In the present study, alteration of mitochondrial membrane potential, ROS and lipid peroxidation were significantly higher in HBE cells exposed to Al2O3 NPs after 12 or 24 h treatment, while prominent enhancement of apoptosis and gene modulation were observed 24 h after treatment. Therefore, the mitochondria-involved dysfunction could account for Al2O3 NPs induced gene modulations and subsequent apoptosis. Significantly, the antioxidant ALCAR reduced cell apoptosis effectively, suggesting that mitochondria associated oxidative stress is involved in Al2O3 NP cytotoxicity.

The carnitine: acylcarnitine translocase (CACTL) located in the mitochondrial inner membrane facilitates cytosolic ALCAR entry into the mitochondria [41]. Inside the mitochondrial matrix, carnitine palmityltransferase II releases carnitine from ALCAR. Carnitine is then transported back across the membrane by carnitine-acylcarnitine translocase [42]. Therefore, ALCAR is considered a specific intramitochondrial acetyl-donor and may be involved in restoring mitochondrial function [43]. ALCAR and its derivative L-carnitine supplementation have wide clinical applications to restore neurologic disorders [44] or improve liver function [42]. Our studies using metabolomics suggest ALCAR levels decrease dramatically due to Al2O3 NP exposure. Because ALCAR is reported to improve mitochondrial function and restore mitochondrial gene expression, [45] we supplemented HBE cells and mice with ALCAR during exposure to Al2O3 NPs. ALCAR treatment significantly increased cell viability and decreased apoptosis, corresponding to decreased caspase activity and cytochrome c release. Additionally, ALCAR reduced oxidative stress and lipid peroxidation due to Al2O3 NP exposure. ALCAR supplementation fully or partially rescued altered gene expression of mitochondrial-associated proteins due to Al2O3 NP exposure. Consistent with our studies, treating rats with ALCAR rescued the function of complexes I, IV and V in brain mitochondria [46]. ALCAR additionally reduced ROS production and ATP depletion in an in vitro cell model [26]. We observed that ALCAR could partially restore oxidative stress and lipid peroxidation induced by a powerful mitochondrial uncoupling agent CCCP, therefore demonstrating strong anti-oxidative activities in the present study.

NADH dehydrogenase (complex I) and cytochrome c oxidase (complex IV) are highly susceptible to oxidative damage [47, 48]. Our data indicate that genes involved in complex I, IV, and V were significantly down-regulated in both Al2O3 NP-treated HBE cells and in lung tissues harvested from mice exposed to Al2O3 NPs, suggesting that loss of mitochondrial function may be due to compromised NADH-linked respiration and complex I-driven electron transport. Furthermore, our data suggests that ALCAR may be useful in maintaining ATP levels under specific pathologic conditions [21]. ALCAR can partially restore the gene expression level in complex I and completely restore gene expression level in complex IV and V, consistent with previous reports that ALCAR protects key mitochondrial enzymes (complex I and IV) from oxidative damage.

In the present study, ALCAR rescued HBE cells against Al2O3 NPs induced apoptosis, which is attributed to the anti-oxidative activities and gene restoration. Further, ALCAR could be a specific supplement according to our metabolomics assays because it was the most significantly down-regulated small molecule metabolite following Al2O3 NPs exposure. However, studies on the involved metabolic pathways and underlying mechanisms are further required.

Conclusions

In summary, we present a approach based on transcriptomics coupled with metabolomics methods, to reveal key genes involved in response to engineered Al2O3 NPs. These nano-scale Al2O3 particles are abundant in either occupational environments or as components of particulate matters in the ambient environment. RNA microarray revealed that down-regulated genes were mainly associated with mitochondrial complexes I and IV and oxidative stress. Treatment with the antioxidant ALCAR which is screened according to the metabolomics analysis was tested in our metabolomics study, and restored mitochondrial function through both in vivo and in vitro studies. We suggest that our “omics” technologies can be used to identify specific pathways involved in toxicities due to Al2O3 NPs and provides insight into identifying potential treatment solutions. Our study is the first to demonstrate the use of ALCAR to restore mitochondrial function and protect cell toxicity from Al2O3 NP exposure in vivo and in vitro.

Methods

Nanomaterials and animals

Al2O3 NPs were purchased from Plasmachem GmbH, Germany (>99.8 % purity). The particle size and zeta potential of Al2O3 NPs in PBS suspension was 64.17 nm and 37.1 mV, which was analyzed by a zetasizer (nano-zs90, Malvern Instruments, UK) (Additional file 1: Figure S3).

Thirty-six male and 36 female ICR mice (20–22 g) were purchased from Shanghai SLRC Laboratory Animal Co. Ltd., China.

Cell culture and RNA extraction

The human bronchial epithelial cell line (HBE) (American Type Culture Collection) was maintained in Dulbecco’s modified Eagle’s medium (DMEM) at 37 °C in 5 % CO2. The culture medium was supplemented with 10 % (v/v) fetal bovine serum (FBS), penicillin (100 U/ml), and streptomycin (100 μg/ml). Cells were seeded in 10 cm culture dishes and exposed to 100 μg/ml Al2O3 NPs with three biological replicates. At 24 h post treatment, complete medium was removed and adherent cells were collected. Total RNA was extracted using the TRIZOL reagent (Invitrogen, U.S.) according to the manufacturer’s instructions.

RNA microarray and gene expression analysis

An Agilent Array platform (Agilent Technologies, Santa Clara, CA, USA) was employed for microarray analysis. The labeled cRNAs were hybridized onto a Human LncRNA Array v3.0 (8 × 60 K; arraystar) chip designed for 26 109 coding genes. The arrays were scanned using an Agilent G2505C scanner and the fluorescence intensity was analyzed with Agilent Feature Extraction software (version 11.0.1.1). Quantile normalization and subsequent data processing were performed using the GeneSpring Gx v12.0 software package (Agilent Technologies). An absolute fold change of 2 or more and 0.05 adjusted P-value were set as cutoff to evaluate the significance of gene expression differences of raw data.

Functional group analysis

DAVID 6.7 (Database for Annotation, Visualization, and Integrated Discovery), a functional annotation tool, was used to analyze differentially expressed genes. The DAVID functional annotation cluster tool provides three structured networks of defined terms that describe the attributes of gene products. The P-value was set to 0.1 to denote the significance of GO enrichment in the differentially expressed mRNA list. Fold enrichment (-lg (P-value)) was used to denote the enrichment of a particular GO term. Pathway analysis for differentially expressed mRNAs was performed on the KEGG database. This analysis determines the biological pathways for which a significant enrichment of differentially expressed mRNAs exist (P-value was set as 0.05).

Metabolomics analysis of Al2O3 NPs treated HBE cells

GC/TOFMS analysis was performed using an Agilent 7890 gas chromatography system coupled with a Pegasus 4D time-of-flight mass spectrometer. HBE cells were exposed to Al2O3 NPs (0, 100, and 500 μg/ml) for 24 h with 9 biological replicates. Then the cell lysate sample were prepared and analyzed as described [16].

Animal treatment

Mice were maintained and used according to the guidelines of the Committee on Animal Use and Care of Southeast University. The dynamic inhalation exposure chambers were outfitted with an aerosol generator (Beijing HuiRongHe Technology Co., Ltd, China). . Mice were divided into six groups (with six male and six female mice in each group): control, mice treated with 100 mg/kg ALCAR, mice treated with low and high doses of Al2O3 NPs, mice treated with a low dose of Al2O3 NPs + 100 mg/kg ALCAR, and mice treated with a high dose of Al2O3 NPs + 100 mg/kg ALCAR. Mice were housed six per polycarbonate cage on corncob bedding with ad libitum access to food and water. Exposure was carried out in three whole-body inhalation chambers; two chambers received low or high dose of Al2O3 NPs and the control chamber received HEPA-filtered clean air at the same flow rates as the experimental groups. Six males and six females were exposed in each chamber for 8 h per day for 7 consecutive days. Light cycles were set on a 12/12 h light/dark cycle. Al2O3 NPs in the chamber were generated by the aerosol generator and mean concentrations of Al2O3 NPs were 2 mg/m3 and 10 mg/m3 for low and high dose treatments, respectively. The concentration of Al2O3 NPs were monitored by an extensive air quality monitoring equipment (CEL-712 Microdust Pro, CASELLA, UK). 100 mg/kg ALCAR was orally administrated by gavage. The temperature, air flow rate and relative humidity in the chambers was set to 22.5 °C, 40 L/min, and 50 ± 10 %.

Histopathological analysis of mice lung tissue

Mice were euthanized under ether anesthesia 1 h after the end of dynamic Al2O3 NP exposure on the 7th day. All the mice were decaptitated on an iced table. Lung tissue was divied for three parts. One piece was immediately prepared for capasse activity, ATP level, ROS and MDA analysis. The second piece was stored in liquid nitrogen, while another piece was preserved in 4 % paraformaldehyde (PFA) for 24 h at 4 °C, embedded in paraffin, serially sectioned (5 μm) and mounted on silane-covered slides. After dewaxing, the sections selected from each mouse were stained with hematoxylin and eosin (HE) and evaluated under a light microscope (400×) to examine the histology of the lung tissues. The severity of pathological lesions was scored according to Szapiel’s method (Additional file 1: Table S1) [49].

Apoptotic cells in lung tissues were evaluated through Terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) staining by a Roche In Situ Cell Death Detection Kit (Roche, U.S.) according to the suggested protocols. The proportion of TUNEL-positive cells of bronchial epithelia were estimated by an experienced histologists blinded to treatment conditions. Five non-overlapping bronchial tubes of each section were counted in high-power fields (HPFS, ×400 magnification) and analyzed. The bronchial tubes had a maximum of positive cells were selected.

Cell viability

Cellular viability was evaluated by a CCK-8 proliferation assay using a Cell Counting Kit-8 (Nanjing Jiancheng Bioengineering Institute, China). HBE cells were plated at a density of 1 × 104 per well in a 96-well plate and treated with 0, 12.5, 25, 50, 100, 250, 500, 1 000 μg/ml (corresponding to 0, 3.91, 7.81, 15.62, 31.25, 78.13, 156.25, 312.5 μg/cm2) Al2O3 NPs with eight biological replicates for each concentration. 10 μL of CCK-8 was added to each well, cells were incubated for 4 h at 37 °C, and the absorbance was determined at 450 nm. Cell viability affected by Al2O3 NPs were monitored every 24 h for up to 7 days.

Cell apoptosis analysis

Apoptosis was assessed by flow cytometry using a KeyGEN Annexin V-FITC Apoptosis Detection Kit (KeyGEN BioTECH, China) according to the manufacturer’s instructions. Briefly, after exposure to 100 or 500 μg/ml Al2O3 NPs for 12 or 24 h, HBE cells were harvested and incubated with 5 μl FITC-conjugated annexin V and 5 μl PI for 15 min at room temperature in the dark. The samples were analyzed by a FACS Calibur Flow Cytometer (BD Biosciences, USA).

Assessment of caspase-3, caspase-8, and caspase-9 activities

Caspase activity assay kits (Beyotime Institute of Biotechnology, China) were used to evaluate caspase-3, 8, and 9 activities in HBE cell lysates and lung tissues according to the manufacturer’s instructions. Briefly, 0.05 g lung tissues were homogenized with 500 μl lysis buffer on ice. cells were lysed with lysis buffer. Protein content was measured by the Bradford method. Ac-DEVD-pNA, Ac-IETD-pNA, Ac-LEHD-pNA were substrate peptides of caspase-3, 8, and 9 respectively, and incubated with Al2O3 NPs-treated cell or lung tissue lysate for 2 h at 37 °C. The release of p-nitroanilide (pNA) from substrates was measured at 405 nm by a microplate reader (Molecular Devices, U.S.).

Mitochondria functions analysis

ATP levels were measured using a luciferase ATP assay kit (Beyotime, China). Briefly, 200 μL of lysis buffer was added to cells treated or untreated with Al2O3 NPs. Cells were collected and centrifuged at 12 000 rpm for 5 min at 4 °C. 0.05 g lung tissue were homogenized with 250 μl lysis buffer, then centrifuged at 12,000 rpm for 5 min at 4 °C. The luminescence of the supernatant was assayed by a luminometer (Berthold Detection System, Pforzheim, Germany). The cationic dye JC-1 was used to detect the mitochondrial membrane potential, and HBE cells exposed to Al2O3 NPs 12 or 24 h were evaluated under a fluorescence microscope (Olympus, Japan) to examine green and red fluorescence.

To determine the release of cytochrome c, mitochondrial and cytosolic proteins were isolated by a Mitochondria/Cytosol Fractionation Kit (Beyotime, China) according to the manufacturer’s instructions. The protein concentrations in cytosol and mitochondria samples were measured using the Bradford method. The levels of cytochrome c were estimated according to the ELISA kit procedures (R&D Systems, U.S.). For all of these mitochondrial-involved assays, CCCP was employed as positive control.

Measurements of reactive oxygen species (ROS), superoxide (O2 .-), hydrogen peroxide (H2O2) and malondialdehyde (MDA) levels

After 12 or 24 h exposure to 100 or 500 μg/ml Al2O3 NPs, HBE cells were washed with PBS. 0.05 g fresh mice lung were homogenized by with 1 mL PBS, and centrifuged at 1,600 g for 10 min at 4 °C. Then DCFH-DA probe was added (Beyotime, China) with a final concentration of 10 μmol/L to determine the content of intracellular ROS. The fluorescence intensity was measured after 30 min incubation at 37 °C under a fluorescence microscope (Olympus, Japan), and quantified by a fluorescence spectrophotometer. O2 .- levels in the cell lysate were determined by WST-1 assay. The concentration of formazan, the reduced product of NBT was measured at 560 nm. H2O2 concentration in cells was determined by optical density (OD) at 560 nm, indicative of H2O2 oxidization of trivalent ferric and xylenol orange. The concentrations of MDA in cellular and lung tissue lysate were assessed by measuring thiobarbituric-acid (TBA) reacting substances at 532 nm. The level of MDA was expressed as nmol MDA per milligram protein. Protein content was measured by Bradford method. For all of these oxidative stress and lipid peroxidation related assays, CCCP was employed as positive control.

ALCAR rescue to Al2O3 NPs induced mitochondrial dysfunction

Cell viability of HBE cells treated with PBS, 0.1, 0.3 mg/ml ALCAR, 500 μg/ml Al2O3 NPs, 0.1 mg/ml ALCAR + 500 μg/ml Al2O3 NPs, or 0.3 mg/ml ALCAR + 500 μg/ml Al2O3 NPs was assessed to determine an appropriate therapeutic dose of ALCAR.

To validate the protective effects of ALCAR against mitochondrial dysfunction, HBE cells were treated with PBS, 100, 500 μg/ml Al2O3 NPs, 0.3 mg/ml ALCAR, 0.3 mg/ml ALCAR+ 100 μg/ml Al2O3 NPs or 0.3 mg/ml ALCAR+ 500 μg/ml Al2O3 NPs for 24 h. Then mitochondrial membrane potential, ROS, ATP, MDA levels, caspase-3, 8, and 9 activities, and O2 .- levels in HBE cells were determined.

RNA isolation and quantitative real-time PCR assay

HBE cells were seeded in 6-well plates at a density of about 1 × 106 cells per well, and exposed to 50, 100, 250, or 500 μg/ml Al2O3 NPs or control medium for 24 h, then cells were trypsinized and collected. The mice lung tissue stored in liquid nitrogen were homogenized in ice-cold 50 mM Tris–HCl buffer (pH 7.55).

Total RNA of HBE cells and lung tissues were extracted using a GenEluteTM Mammalian Total RNA Miniprep Kit (Sigma, U.S.) according to the manufacturer’s protocol, and the concentration of total RNA was determined by measuring the absorbance at 260 nm using a Nanodrop 2000c spectrophotometer (Thermo Scientific, U.S.). cDNA synthesis for coding genes was performed with 1ug of total RNA according to the manufacturer’s instruction (Takara, Japan).

The mRNA levels for modulated genes were determined by reverse transcription of total RNA followed by quantitative real-time PCR analysis (qRT-PCR) on a Quant Studio 6 Flex system (Applied Biosystems, Life Technologies, U.S.) using SYBR PCR Master Mix reagent kits (Takara, Japan) following the manufacturer’s protocol. Primers were designed for the modulated genes screened by RNA microarray, and are provided in Additional file 1: Table S2 and S3. All experiments were performed in triplicate. The mRNA levels provided were normalized to cyclophilin A.

Data analysis

Values of cell viability, apoptosis, and mitochondrial dysfunction assays are expressed as mean ± standard error of the mean (SE). Statistically significant differences were determined by one-way ANOVA, followed by Dunnett’s multiple comparison tests. Kruskal-Wallis test was used to analyze the ranked data of pulmonary lesion scores. The method of 2 –ΔΔCt was used to analyze the results of RT-PCR in all experiments. Statistical analysis was performed by SPSS12.0 and the significance was set at P < 0.05.

Notes

Abbreviations

Al2O3

aluminum oxide

ALCAR: 

acetyl-L-carnitine

Apaf-1: 

apoptosis protease activating factor-1

CACTL: 

carnitine: acylcarnitine translocase

FBS: 

fetal bovine serum

GO: 

gene ontology

GSH: 

glutathione

H2O2

hydrogen peroxide

HBE: 

human bronchial epithelial

HE: 

hematoxylin and eosin

HEPG2: 

human hepatocarcinoma

KEGG: 

Kyoto encyclopedia of genes and genomes

MDA: 

malondialdehyde

MOMP: 

mitochondrial outer membrane permeabilization

NPs: 

nanoparticles

O2 .-

superoxide

PFA: 

paraformaldehyde

PM2.5

fine particulate matter

ROS: 

reactive oxygen species

SE: 

standard error of the mean

SWCNTs: 

single-walled carbon nanotubes

TBA: 

thiobarbituric-acid

Declarations

Acknowledgements

This work was financially supported by National Natural Science Foundation of China (Grant No. 81472938), the Natural Science Foundation of Jiangsu Province (BK20151418), the fund of the Distinguished talents of Jiangsu Province (BK20150021) the fund of the Distinguished Professor of Jiangsu Province, the Open Research Fund of State Key Laboratory of Bioelectronics, Southeast University, the fund of the post-graduate innovative talents (Grant No. SJZZ_0033), and the Fundamental Research Funds for the Central Universities. We thank Nanjing Milestone Biotechnology Co. LTD for mRNA microarray and metabolomics data processing for this manuscript.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China
(2)
Center for Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, China
(3)
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China
(4)
State Key Laboratory of Bioelectronics, Southeast University, Nanjing, China

References

  1. Mills NL, Donaldson K, Hadoke PW, Boon NA, MacNee W, Cassee FR, et al. Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med. 2009;6:36–44.PubMedView ArticleGoogle Scholar
  2. Lu S, Zhang W, Zhang R, Liu P, Wang Q, Shang Y, et al. Comparison of cellular toxicity caused by ambient ultrafine particles and engineered metal oxide nanoparticles. Part Fibre Toxicol. 2015;12:5.PubMedPubMed CentralView ArticleGoogle Scholar
  3. Huang Y, Lu X, Ma J. Toxicity of silver nanoparticles to human dermal fibroblasts on microRNA level. J Biomed Nanotechnol. 2014;10:3304–17.PubMedView ArticleGoogle Scholar
  4. Thit A, Selck H, Bjerregaard HF. Toxic mechanisms of copper oxide nanoparticles in epithelial kidney cells. Toxicol In Vitro. 2015;29:1053–9.PubMedView ArticleGoogle Scholar
  5. Shi Y. A structural view of mitochondria-mediated apoptosis. Nat Struct Biol. 2001;8:394–401.PubMedView ArticleGoogle Scholar
  6. Xiong S, Mu T, Wang G, Jiang X. Mitochondria-mediated apoptosis in mammals. Protein Cell. 2014;5:737–49.PubMedPubMed CentralView ArticleGoogle Scholar
  7. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011;12:222–30.PubMedPubMed CentralView ArticleGoogle Scholar
  8. Talla V, Koilkonda R, Porciatti V, Chiodo V, Boye SL, Hauswirth WW, et al. Complex I subunit gene therapy with NDUFA6 ameliorates neurodegeneration in EAE. Invest Ophthalmol Vis Sci. 2015;56:1129–40.PubMedPubMed CentralView ArticleGoogle Scholar
  9. Cao X, Yap JL, Newell-Rogers MK, Peddaboina C, Jiang W, Papaconstantinou HT, et al. The novel BH3 alpha-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak. Mol Cancer. 2013;12:42.PubMedPubMed CentralView ArticleGoogle Scholar
  10. Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov. 2010;9:447–64.PubMedView ArticleGoogle Scholar
  11. Li R, Kou X, Geng H, Xie J, Tian J, Cai Z, et al. Mitochondrial damage: an important mechanism of ambient PM2.5 exposure-induced acute heart injury in rats. J Hazard Mater. 2015;287:392–401.PubMedView ArticleGoogle Scholar
  12. Stapleton PANC, Yi J, McBride CR, Minarchick VC, Shepherd DL, Hollander JM, et al. Microvascular and mitochondrial dysfunction in the female F1 generation after gestational TiO2 nanoparticle exposure. Nanotoxicology. 2014;5:1–11.Google Scholar
  13. Yu KN, Yoon TJ, Minai-Tehrani A, Kim JE, Park SJ, Jeong MS, et al. Zinc oxide nanoparticle induced autophagic cell death and mitochondrial damage via reactive oxygen species generation. Toxicol In Vitro. 2013;27:1187–95.PubMedView ArticleGoogle Scholar
  14. Collins FS, Gray GM, Bucher JR. Toxicology. Transforming environmental health protection. Science. 2008;319:906–7.PubMedPubMed CentralView ArticleGoogle Scholar
  15. Nel A, Xia T, Meng H, Wang X, Lin S, Ji Z, et al. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc Chem Res. 2013;46:607–21.PubMedPubMed CentralView ArticleGoogle Scholar
  16. Xu B, Chen M, Ji X, Mao Z, Zhang X, Wang X, et al. Metabolomic profiles delineate the potential role of glycine in gold nanorod-induced disruption of mitochondria and blood-testis barrier factors in TM-4 cells. Nanoscale. 2014;6:8265–73.PubMedView ArticleGoogle Scholar
  17. Hanagata N, Zhuang F, Connolly S, Li J, Ogawa N, Xu M. Molecular responses of human lung epithelial cells to the toxicity of copper oxide nanoparticles inferred from whole genome expression analysis. ACS Nano. 2011;5:9326–38.PubMedView ArticleGoogle Scholar
  18. Foldbjerg R, Irving ES, Hayashi Y, Sutherland DS, Thorsen K, Autrup H, et al. Global gene expression profiling of human lung epithelial cells after exposure to nanosilver. Toxicol Sci. 2012;130:145–57.PubMedView ArticleGoogle Scholar
  19. Shim W, Paik MJ, Nguyen DT, Lee JK, Lee Y, Kim JH, et al. Analysis of changes in gene expression and metabolic profiles induced by silica-coated magnetic nanoparticles. ACS Nano. 2012;6:7665–80.PubMedView ArticleGoogle Scholar
  20. Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer’s disease and geriatric depression. Mol Psychiatry. 2000;5:616–32.PubMedView ArticleGoogle Scholar
  21. Patel SP, Sullivan PG, Lyttle TS, Rabchevsky AG. Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury. J Neurochem. 2010;114:291–301.PubMedPubMed CentralGoogle Scholar
  22. Musicco C, Capelli V, Pesce V, Timperio AM, Calvani M, Mosconi L, et al. Accumulation of overoxidized Peroxiredoxin III in aged rat liver mitochondria. Biochim Biophys Acta. 2009;1787:890–6.PubMedView ArticleGoogle Scholar
  23. Aureli T, Puccetti C, Di Cocco ME, Arduini A, Ricciolini R, Scalibastri M, et al. Entry of [(1,2-13C2)acetyl]-L-carnitine in liver tricarboxylic acid cycle and lipogenesis: a study by 13C NMR spectroscopy in conscious, freely moving rats. Eur J Biochem. 1999;263:287–93.PubMedView ArticleGoogle Scholar
  24. Annadurai T, Vigneshwari S, Thirukumaran R, Thomas PA, Geraldine P. Acetyl-L-carnitine prevents carbon tetrachloride-induced oxidative stress in various tissues of Wistar rats. J Physiol Biochem. 2011;67:519–30.PubMedView ArticleGoogle Scholar
  25. Di Cesare ML, Ghelardini C, Calvani M, Nicolai R, Mosconi L, Vivoli E, et al. Protective effect of acetyl-L-carnitine on the apoptotic pathway of peripheral neuropathy. Eur J Neurosci. 2007;26:820–7.View ArticleGoogle Scholar
  26. Dhitavat S, Ortiz D, Shea TB, Rivera ER. Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels. Neurochem Res. 2002;27:501–5.PubMedView ArticleGoogle Scholar
  27. Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med. 2012;18:684–92.PubMedView ArticleGoogle Scholar
  28. Madl AK, Plummer LE, Carosino C, Pinkerton KE. Nanoparticles, lung injury, and the role of oxidant stress. Annu Rev Physiol. 2014;76:447–65.PubMedPubMed CentralView ArticleGoogle Scholar
  29. Shvedova AA, Kisin E, Murray AR, Johnson VJ, Gorelik O, Arepalli S, et al. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol. 2008;295:L552–65.PubMedPubMed CentralView ArticleGoogle Scholar
  30. Sager T, Wolfarth M, Keane M, Porter D, Castranova V, Holian A. Effects of nickel-oxide nanoparticle pre-exposure dispersion status on bioactivity in the mouse lung. Nanotoxicology. 2015;28:1–11.View ArticleGoogle Scholar
  31. Pisani C, Gaillard JC, Nouvel V, Odorico M, Armengaud J, Prat O. High-throughput, quantitative assessment of the effects of low-dose silica nanoparticles on lung cells: grasping complex toxicity with a great depth of field. BMC Genomics. 2015;16:315.PubMedPubMed CentralView ArticleGoogle Scholar
  32. Pinkerton KE, Green FH, Saiki C, Vallyathan V, Plopper CG, Gopal V, et al. Distribution of particulate matter and tissue remodeling in the human lung. Environ Health Perspect. 2000;108:1063–9.PubMedPubMed CentralView ArticleGoogle Scholar
  33. Nymark P, Wijshoff P, Cavill R, van Herwijnen M, Coonen ML, Claessen S, et al. Extensive temporal transcriptome and microRNA analyses identify molecular mechanisms underlying mitochondrial dysfunction induced by multi-walled carbon nanotubes in human lung cells. Nanotoxicology. 2015;9(5):624–35.PubMedGoogle Scholar
  34. Siddiqui MA, Alhadlaq HA, Ahmad J, Al-Khedhairy AA, Musarrat J, Ahamed M. Copper oxide nanoparticles induced mitochondria mediated apoptosis in human hepatocarcinoma cells. PLoS One. 2013;8:e69534.PubMedPubMed CentralView ArticleGoogle Scholar
  35. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9:47–59.PubMedView ArticleGoogle Scholar
  36. Marchi S, Giorgi C, Suski JM, Agnoletto C, Bononi A, Bonora M, et al. Mitochondria-ros crosstalk in the control of cell death and aging. J Signal Transduct. 2012;2012:329635.PubMedPubMed CentralView ArticleGoogle Scholar
  37. Van Houten B, Woshner V, Santos JH. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amst). 2006;5:145–52.Google Scholar
  38. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3:279–90.PubMedView ArticleGoogle Scholar
  39. Ahamed M, Akhtar MJ, Raja M, Ahmad I, Siddiqui MK, AlSalhi MS, et al. ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress. Nanomedicine. 2011;7:904–13.PubMedView ArticleGoogle Scholar
  40. Manke A, Wang L, Rojanasakul Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed Res Int. 2013;2013:942916.PubMedPubMed CentralView ArticleGoogle Scholar
  41. Indiveri C, Iacobazzi V, Tonazzi A, Giangregorio N, Infantino V, Convertini P, et al. The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology. Mol Aspects Med. 2011;32:223–33.PubMedView ArticleGoogle Scholar
  42. Kathirvel E, Morgan K, French SW, Morgan TR. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. Nutr Res. 2013;33:932–41.PubMedView ArticleGoogle Scholar
  43. Tong X, Christian P, Zhao M, Wang H, Moreau R, Su Q. Activation of hepatic CREBH and Insig signaling in the anti-hypertriglyceridemic mechanism of R-alpha-lipoic acid. J Nutr Biochem. 2015;26(9):921–8.PubMedView ArticleGoogle Scholar
  44. Malaguarnera M. Carnitine derivatives: clinical usefulness. Curr Opin Gastroenterol. 2012;28:166–76.PubMedView ArticleGoogle Scholar
  45. Cassano P, Sciancalepore AG, Pesce V, Fluck M, Hoppeler H, Calvani M, et al. Acetyl-L-carnitine feeding to unloaded rats triggers in soleus muscle the coordinated expression of genes involved in mitochondrial biogenesis. Biochim Biophys Acta. 2006;1757:1421–8.PubMedView ArticleGoogle Scholar
  46. Long J, Gao F, Tong L, Cotman CW, Ames BN, Liu J. Mitochondrial decay in the brains of old rats: ameliorating effect of alpha-lipoic acid and acetyl-L-carnitine. Neurochem Res. 2009;34:755–63.PubMedPubMed CentralView ArticleGoogle Scholar
  47. Vazquez-Memije ME, Capin R, Tolosa A, El-Hafidi M. Analysis of age-associated changes in mitochondrial free radical generation by rat testis. Mol Cell Biochem. 2008;307:23–30.PubMedView ArticleGoogle Scholar
  48. Roy Chowdhury SK, Sangle GV, Xie X, Stelmack GL, Halayko AJ, Shen GX. Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells. Am J Physiol Endocrinol Metab. 2010;298:E89–98.PubMedView ArticleGoogle Scholar
  49. Szapiel SVEN, Fulmer JD, Hunninghake GW, Crystal RG. Bleomycin-induced interstitial pulmonary diseases in the nude, athymic mouse. Am Rev Resp Dis. 1979;120:7.Google Scholar

Copyright

© Li et al. 2016

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement